Page last updated: 2024-08-21

nicotinamide mononucleotide and Dermatitis, Atopic

nicotinamide mononucleotide has been researched along with Dermatitis, Atopic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, L; Ding, H; Gao, JF; Luo, F; Meng, ZD; Tang, L; Zhang, YY1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and Dermatitis, Atopic

ArticleYear
Nicotinamide mononucleotide ameliorates DNFB-induced atopic dermatitis-like symptoms in mice by blocking activation of ROS-mediated JAK2/STAT5 signaling pathway.
    International immunopharmacology, 2022, Volume: 109

    Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Mice; Nicotinamide Mononucleotide; Pruritus; Reactive Oxygen Species; Signal Transduction; Skin; STAT5 Transcription Factor; Tumor Necrosis Factor-alpha

2022